Cartalax Research for Cartilage Degeneration / Osteoarthritis

Cartalax is proposed to support cartilage tissue through chondrocyte gene regulation based on the Khavinson bioregulator framework. Russian in-vitro research reports increased Ki-67 and CD98hc expression markers in chondrocyte cultures, suggesting enhanced proliferation and regenerative capacity. Cell culture studies also propose MMP-9 inhibition, which could theoretically reduce degradation of cartilage extracellular matrix. Critically, all evidence is preclinical — no controlled human clinical trials for osteoarthritis or cartilage degeneration have been conducted. All research originates from Russian institutes with no independent replication.